Posted by AGORACOM-JC
at 12:40 PM on Friday, April 3rd, 2020
Global Leaders in Mobile ECG Connectivity
20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring platforms, research groups and commercial call centers
Sold into > 20 countries, with the largest customer base located in the US
Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and storing of ECGs for management of patient and consumer health
ECG solutions for both consumer (OTC) and medical (Rx) markets
Owns all IP and source code
Market expert contributor for reports in mâ€health, mobile cardiac monitoring and new advances in consumer health and wellness monitoring
Recent Highlights
CardioComm Solutions Partners with CareOS to Bring Consumer ECG Monitoring into the Connected Home
Entered into a partnership agreement with CareOS SAS (France), a subsidiary of Baracoda Group, to provide consumer ECG monitoring technologies through the CareOS Poseidon smart mirror health and beauty hub
The partnership will see CardioComm’s FDA and Health Canada cleared GEMS™ ECG management software and Smart Monitoring ECG reading service integrated into the touch and gesture controlled smart mirror
GEMSTM software will be capable of recognizing ECG devices made by multiple device manufacturers which will permit CareOS customers more options in choosing a device of their preference.
Posted by AGORACOM-JC
at 11:49 AM on Wednesday, April 1st, 2020
SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.
mHealth Project to Crowdsource Consumer Data for Coronavirus Research
UCSF researchers are deploying an mHealth app to gather information on daily health habits
They’re hoping to gain insight on how behaviors might affect the course of the virus or outcomes in those who are infected
March 31, 2020 – mHealth researchers are using smartphones to crowdsource Coronavirus research.
The University of California at San Francisco has launched COVID-19 Citizen Science (CCS), a project aimed at gathering insights from people around the world on the virus. Participants are being asked to download an mHealth app, complete a survey about their daily health habits, complete a weekly follow-up survey and pass it on to friends.
“We are asking each participant to share the link to recruit at least five others,†Gregory Marcus, MD, MAS, a professor at UCSF’s Department of Medicine and the project’s co-leader, said in a press release. “We want to demonstrate that the number of people signing up for this scientific study and contributing their data can increase exponentially, faster than the disease itself.â€
Participants will also be able to provide continuous GPS data and information from mHealth wearables, such as Fitbit activity bands and smartwatches.
(For more coronavirus updates, visit our resource page, updated twice daily by Xtelligent Healthcare Media.)
Marcos is no stranger to telehealth projects. In 2013 he helped to launch the Health eHeart Study, which used online and mHealth tools to collect and analyze heart health data. That, in turn, led to the launch of a study in 2018 that combined mHealth wearables with AI to determine whether a cardiac monitoring platform could help detect early signs of diabetes.
Marcos says CCS aims to identify behaviors, influences and factors that might affect the course of the virus and outcomes after infection, and he feels the study could be the largest-ever prospective epidemiological study of infectious diseases.
“Social distancing keeps many protected,†he said, “but joining together to contribute data will help us beat this thing.â€
Posted by AGORACOM-JC
at 4:02 PM on Tuesday, March 31st, 2020
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
‘Smart’ devices help reduce adverse outcomes of common heart condition
mHealth devices, such as fitness trackers, smart watches and mobile phones, may enable earlier AF detection, and improved AF management through the use of photoplethysmography (PPG) technology
AF is the most common heart rhythm disturbance, affecting around one million people in the UK. People with AF are at increased risk of having a stroke and dying, as well as heart failure and dementia
A new study, published in the Journal of the American College of Cardiology,
highlights the feasible use of mobile health (mHealth) devices to help
with the screening and detection of a common heart condition.
Atrial fibrillation (AF) is a heart rhythm condition that causes an
irregular and sometimes, abnormally fast heart rate. In AF, the heart’s
upper chambers (atria) contract randomly and sometimes so fast that the
heart muscle cannot relax properly between contractions. This reduces
the heart’s efficiency and performance—but also leads to a higher risk
of blood clots.
AF is the most common heart rhythm disturbance, affecting around one
million people in the UK. People with AF are at increased risk of having
a stroke and dying, as well as heart failure and dementia. Currently,
low detection due to lack of visible symptoms and non-adherence are
major problems in current management approaches for patients with
suspected AF.
Photoplethysmography technology
mHealth devices, such as fitness trackers, smart watches
and mobile phones, may enable earlier AF detection, and improved AF
management through the use of photoplethysmography (PPG) technology.
PPG is a simple and low-cost optical technique that can be used to
detect blood volume changes in the microvascular bed of tissue. It is
often used non-invasively to make measurements at the skin surface.
To help determine whether a mHealth technology-supported AF
integrated management strategy would reduce AF-related adverse events,
compared to usual care, an international team of researchers, led by
Associate Professor Guo from Chinese PLA General Hospital in Beijing,
and Professor Gregory Lip, Lead for the Liverpool Centre for
Cardiovascular Science (LCCC)/Price-Evans Chair of Cardiovascular
Medicine at University of Liverpool, conducted a randomised trial.
Central to the study was mobile health technologies developed by
leading global technology companies, with a focus on using wearable
smart devices such as those from Huawei, working in conjunction with a
specially developed mobile app. These pieces of equipment and software
can monitor a person’s vital signs with great detail and, most
importantly for this study, 24 hours a day.
The specially designed mobile app
not only charted the patient’s biometrics, it afforded clinicians the
ability to offer integrated care throughout the duration of the trial.
Doctors were able to periodically assess the patient’s updated
statistics and contact them through the app to offer advice via the ABC
care pathway. The ABC pathway, developed in part by the LCCS’ Professor
Gregory Lip, is a set of guidance for patients and clinicians, which
aims to promote a streamlined holistic approach to the management of AF, and ensure that the danger of complications is minimised.
The researchers enrolled a cluster of 3,324 AF patients aged over 18
years from 40 cities across China. The patients were randomized with
1678 receiving usual care and 1646 receiving integrated care based on a
mobile AF Application (mAFA) incorporating the ABC Pathway: ‘A’ Avoid
stroke; ‘B’ Better symptom management; ‘C’ Cardiovascular and other
comorbidity risk reduction. All patients were followed up in outpatient
clinics at 6 and 12 months.
Results
Upon completion of the study, the researchers were able to show that
occurrences of stroke, systemic thromboembolism, death and
rehospitalisation were significantly lower with those patients in the
mHealth intervention group compared to those undergoing usual care (1.9%
compared with 6%). Rehospitalisation rates were also notably reduced,
with only 1.2% of patients in the intervention group needing to be
readmitted to hospital, in comparison to 4.5% of patients in the control
group.
In addition to these positive figures, subgroup analyses by gender,
age, type of condition, risk score and comorbidities, demonstrated
consistently lower risks for the composite outcome for patients
receiving the mAFA intervention compared to usual care.
These results show an undeniable benefit for the adoption of an
integrated approach to monitoring and treating cardiac conditions such
as AF.
With smart technologies such as phones, watches and integrated smart
home systems becoming increasingly accessible and affordable, the
ability for clinicians and researchers to adopt this technology to
passively and unobtrusively gather a seemingly unlimited amount of data
and information on the global health population is offering boundless
opportunity for assessing and treating all manner of diseases and
conditions.
Integrated care approach
Associate Professor Guo, said: “Our study clearly highlights the need
for an integrated care approach to holistic AF care, supported by
mobile health technology, as it help to reduce the risks of
rehospitalisation and clinical adverse events.”
Professor Lip, said: “Improved AF care requires early detection which
enables the implementation of the priorities of AF management, which is
as ‘easy as ABC’: Avoid stroke; Better symptom optimisation;
Cardiovascular and risk factor management. Our clinical trial shows how
the mAFA App and smart devices can improve detection of AF and the
holistic management of AF patients, improving outcomes in this common
heart rhythm disorder.”
Posted by AGORACOM-JC
at 5:09 PM on Monday, March 30th, 2020
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
The Tech That Could Be Our Best Hope for Fighting COVID-19—and Future Outbreaks
“The connectivity we have today gives us ammunition to fight this pandemic in ways we never previously thought possible,†says Alain Labrique, director of the Johns Hopkins University Global -mHealth Initiative.
Battling a pandemic as serious as COVID-19
requires drastic responses, and political leaders and public-health
officials have turned to some of the most radical strategies available.
What began with a lockdown of one city in China quickly expanded to the
quarantine of an entire province, and now entire countries including
Italy. While social isolation and curfews are among the most effective
ways to break the chain of viral transmission, some health experts say
it’s possible these draconian measures didn’t have to become a global
phenomenon. “If health officials could have taken action earlier and
contained the outbreak in Wuhan, where the first cases were reported,
the global clampdown could have been at a much more local level,†says
Richard Kuhn, a virologist and professor of science at -Purdue
University.
The key to early response lies in looking beyond centuries-old
strategies and incorporating methods that are familiar to nearly every
industry from banking to retail to manufacturing, but that are still
slow to be adopted in public health. Smartphone apps, data analytics and
artificial intelligence all make finding and treating people with an
infectious disease far more efficient than ever before.
“The connectivity we have today gives us ammunition to fight this
pandemic in ways we never previously thought possible,†says Alain
Labrique, director of the Johns Hopkins University Global -mHealth
Initiative. And yet, to date, the global public–health response to
COVID-19 has only scratched the surface of what these new containment
tools offer. Building on them will be critical for ensuring that the
next outbreak never gets the chance to explode from epidemic to global
pandemic.
Consider how doctors currently detect new cases of COVID-19. Many
people who develop the hallmark symptoms of the -disease—fever, cough
and shortness of breath—-physically visit a primary-care doctor, a
health care provider at an urgent-care center or an emergency room. But
that’s the last thing people potentially infected with a highly
contagious disease should do. Instead, health officials are urging them
to connect remotely via an app to a doctor who can triage their symptoms
while they’re still at home.
“The reality is that clinical brick-and-mortar medicine is rife with
the possibility of virus exposure,†says Dr. Jonathan Wiesen, founder
and chief medical officer of MediOrbis, a telehealth company. “The
system we have in place is one in which everyone who is at risk is
potentially transmitting infection. That is petrifying.†Instead, people
could call a telemedicine center and describe their symptoms to a
doctor who can then determine whether they need COVID-19
-testing—without exposing anyone else.
In Singapore, more than a million people have used a popular
telehealth app called -MaNaDr, founded by family physician Dr. Siaw Tung
Yeng, for virtual visits; 20% of the physicians in the island country
offer some level of service via the app. In an effort to control
escalating cases of coronavirus there, people with symptoms are getting
prescreened by physicians on MaNaDr and advised to stay home if they
don’t need intensive care. Patients then check in with their telehealth
doctor every evening and report if their fever persists, if they have
shortness of breath or if they are feeling worse. If they are getting
sicker, the doctor orders an ambulance to take those people to the
hospital. Siaw says the virtual monitoring makes people more comfortable
about staying at home, where many cases can be treated, instead of
flooding hospitals and doctors’ offices, straining limited resources and
potentially making others sick. “This allows us to care across
distance, monitor patients across distance and assess their progression
across distance,†says Siaw. “There is no better time for remote care
monitoring of our patients than now.â€
Other at-home devices and services currently being used in the U.S.
allow patients to measure dozens of health metrics like temperature,
blood pressure and blood sugar several times a day, and the results are
automatically stored on the cloud, from which doctors get alerts if the
readings are abnormal.
Telemedicine also serves as a powerful communication tool for keeping
hundreds of thousands of people in a specific region up to date with
the latest advice about the risk in their communities and how best to
protect themselves. That can go a long way toward reassuring people and
preventing panic and runs on health centers and hospitals.
Beyond individual-level care, the data gathered by telemedicine
services can be mined to predict the broader ebb and flow of an
epidemic’s trajectory in a population. In the U.S., Kaiser Permanente’s
tele-medicine call centers are now also serving as a bellwether for an
anticipated surge in demand for health services. Dr. Stephen Parodi,
national infectious–disease leader at Kaiser Permanente, was inspired by
a Google project from a few years ago in which the company created an
algorithm of users’ flu–related search terms to determine where clusters
of cases were mounting. Parodi started tracking coronavirus–related
calls from the health system’s 4.5 -million members in Northern
California in February. “We went from 200 calls a day to 3,500 calls a
day about symptoms of COVID-19, which was an early indicator of
community–based transmission,†he says. “Our call volume was telling us
several weeks before the country would have all of its testing online
that we have got to plan for a surge in cases.â€
Tags: EKG, mhealth, small cap stocks, stocks Posted in All Recent Posts, CardioComm Solutions | Comments Off on The Tech That Could Be Our Best Hope for Fighting #COVID19 —and Future Outbreaks – SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca
Posted by AGORACOM-JC
at 2:45 PM on Thursday, March 19th, 2020
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
The Tech That Could Be Our Best Hope for Fighting COVID-19—and Future Outbreaks
Battling a pandemic as serious as COVID-19 requires drastic responses, and political leaders and public-health officials have turned to some of the most radical strategies available.
The key to early response lies in looking beyond centuries-old strategies and incorporating methods that are familiar to nearly every industry from banking to retail to manufacturing, but that are still slow to be adopted in public health
Smartphone apps, data analytics and artificial intelligence all make finding and treating people with an infectious disease far more efficient than ever before
What began with a lockdown of one city in China quickly expanded to the quarantine of an entire province, and now entire countries including Italy. While social isolation and curfews are among the most effective ways to break the chain of viral transmission, some health experts say it’s possible these draconian measures didn’t have to become a global phenomenon. “If health officials could have taken action earlier and contained the outbreak in Wuhan, where the first cases were reported, the global clampdown could have been at a much more local level,†says Richard Kuhn, a virologist and professor of science at -Purdue University.
The key to early response lies in looking beyond centuries-old
strategies and incorporating methods that are familiar to nearly every
industry from banking to retail to manufacturing, but that are still
slow to be adopted in public health. Smartphone apps, data analytics and
artificial intelligence all make finding and treating people with an
infectious disease far more efficient than ever before.
“The connectivity we have today gives us ammunition to fight this
pandemic in ways we never previously thought possible,†says Alain
Labrique, director of the Johns Hopkins University Global -mHealth
Initiative. And yet, to date, the global public–health response to
COVID-19 has only scratched the surface of what these new containment
tools offer. Building on them will be critical for ensuring that the
next outbreak never gets the chance to explode from epidemic to global
pandemic.
Consider how doctors currently detect new cases of COVID-19. Many
people who develop the hallmark symptoms of the -disease—fever, cough
and shortness of breath—-physically visit a primary-care doctor, a
health care provider at an urgent-care center or an emergency room. But
that’s the last thing people potentially infected with a highly
contagious disease should do. Instead, health officials are urging them
to connect remotely via an app to a doctor who can triage their symptoms
while they’re still at home.
“The reality is that clinical brick-and-mortar medicine is rife with
the possibility of virus exposure,†says Dr. Jonathan Wiesen, founder
and chief medical officer of MediOrbis, a telehealth company. “The
system we have in place is one in which everyone who is at risk is
potentially transmitting infection. That is petrifying.†Instead, people
could call a telemedicine center and describe their symptoms to a
doctor who can then determine whether they need COVID-19
-testing—without exposing anyone else.
In Singapore, more than a million people have used a popular
telehealth app called -MaNaDr, founded by family physician Dr. Siaw Tung
Yeng, for virtual visits; 20% of the physicians in the island country
offer some level of service via the app. In an effort to control
escalating cases of coronavirus there, people with symptoms are getting
prescreened by physicians on MaNaDr and advised to stay home if they
don’t need intensive care. Patients then check in with their telehealth
doctor every evening and report if their fever persists, if they have
shortness of breath or if they are feeling worse. If they are getting
sicker, the doctor orders an ambulance to take those people to the
hospital. Siaw says the virtual monitoring makes people more comfortable
about staying at home, where many cases can be treated, instead of
flooding hospitals and doctors’ offices, straining limited resources and
potentially making others sick. “This allows us to care across
distance, monitor patients across distance and assess their progression
across distance,†says Siaw. “There is no better time for remote care
monitoring of our patients than now.â€
Other at-home devices and services currently being used in the U.S.
allow patients to measure dozens of health metrics like temperature,
blood pressure and blood sugar several times a day, and the results are
automatically stored on the cloud, from which doctors get alerts if the
readings are abnormal.
Telemedicine also serves as a powerful communication tool for keeping
hundreds of thousands of people in a specific region up to date with
the latest advice about the risk in their communities and how best to
protect themselves. That can go a long way toward reassuring people and
preventing panic and runs on health centers and hospitals.
Beyond individual-level care, the data gathered by telemedicine
services can be mined to predict the broader ebb and flow of an
epidemic’s trajectory in a population. In the U.S., Kaiser Permanente’s
tele-medicine call centers are now also serving as a bellwether for an
anticipated surge in demand for health services. Dr. Stephen Parodi,
national infectious–disease leader at Kaiser Permanente, was inspired by
a Google project from a few years ago in which the company created an
algorithm of users’ flu–related search terms to determine where clusters
of cases were mounting. Parodi started tracking coronavirus–related
calls from the health system’s 4.5 -million members in Northern
California in February. “We went from 200 calls a day to 3,500 calls a
day about symptoms of COVID-19, which was an early indicator of
community–based transmission,†he says. “Our call volume was telling us
several weeks before the country would have all of its testing online
that we have got to plan for a surge in cases.â€
On the basis of the swell in calls nationwide, the hospital system is
considering suspending elective surgeries based on local circumstances,
in part to ensure that ventilators and other critical equipment would
be available for an anticipated influx of COVID-19 patients with severe
symptoms. Kaiser doctors also postponed appointments for routine
mammograms and other cancer–screening tests and cut back on in-person
appointments by turning most noncritical visits into virtual visits.
The COVID-19 pandemic may be the trial by fire that telemedicine
finally needs to prove its worth, especially in the U.S. Despite the
fact that apps and technology for virtual health visits have existed for
several decades, uptake in the country has been slow. Medicare only
recently began reimbursing for telemedicine visits at rates comparable
to in-person visits, and states have just begun to relax licensing
regulations that prevent doctors in one state from -remotely treating
patients in another state. “This -pandemic is almost like us crossing
the Rubicon,†says Wiesen of MediOrbis. “It’s a clarion call for America
and for the world on how important telemedicine is.†Parodi agrees. “I
think this pandemic will bring in a fundamental change in the way we
practice medicine and in the way the health care system functions in the
U.S.,†he says. “We’re going to come out of this and -realize a lot of
health care visits don’t have to be in person.â€
Other tech innovations that haven’t fully made their way to the
public-health sector could also play a critical role in controlling this
-pandemic—and future outbreaks. Taking a closer look at health-related
data, such as electronic health records or sales of over-the-counter
medications, can provide valuable clues about how an infectious disease
like COVID-19 is moving through a population. Retail drugstores track
inventory and sales of nonprescription fever reducers, for example, and
any trends in those data might serve as an early, albeit crude,
harbinger of growing spread of disease in a community. And given the
proliferation of health–tracking apps on smartphones, analyzing data
trends like a rise in average body temperature in a given geographical
area could provide clues to emerging clusters of cases.
Geotracking on phones, while controversial because of privacy issues,
can also streamline the tedious task of contact tracing, in which
scientists try to manually trace infected patients’ whereabouts to find
as many people with whom they had direct contact and who could have been
infected. In South Korea, this strategy helped identify many of the
contacts of members of a Seoul church that formed the first major
cluster of infections in the country. In countries with a less robust
health care infrastructure, smartphones can be critical for gathering
information about emerging infections on the ground. In Bangladesh, says
Labrique, programs created to canvass for noncommunicable diseases like
hyper-tension and diabetes are now being modified to include questions
about COVID-19 symptoms. These types of real-time data can rapidly
provide a snapshot of where and how fast the disease might be spreading,
to distribute health care workers and -equipment where they’re needed
most.
It’s all about catching these cases as early as possible, to minimize
the peak of a pandemic so the health system doesn’t get overwhelmed.
But it’s not just about seeing the trends. Flattening the surge of an
infectious disease also requires action, and that’s where the advice
gets -muddier—but also where Big Data and artificial intelligence (AI)
can provide clarity.
By deeply analyzing the care that every COVID-19 patient receives,
for example, AI can tease out the best treatment strategies. Jvion, a
health care analytics company, is using AI to study 30 million patients
in its data universe to identify people and communities at highest risk
of COVID-19 on the basis of more than 5,000 variables that include not
just medical history but also lifestyle and socioeconomic factors such
as access to stable housing and transportation. Working with clients
that include large hospital systems as well as small remote health
centers, Jvion’s platform creates lists of people who should be
contacted pro-actively to warn them about their vulnerability so health
providers can create a care plan for them.
In the case of COVID-19, that might include social distancing and
avoiding large public gatherings. To help public-health departments
better prepare communities for this and future outbreaks, the company
has communicated with the U.S. Centers for Disease Control and
Prevention to share what it has learned.
Privacy issues, however, nest in every single byte of data about a
person’s health. So the power of AI methods in controlling outbreaks
depends on how effectively data can be anonymized. Only when people are
assured of privacy can algorithms help to navigate the next big hurdle:
predicting surges in cases that strain health care personnel and
availability of supplies like ventilators, masks and gowns.
If COVID-19 teaches public-health officials one thing, it’s that
there are now tools available to help contain an infectious disease
before radical measures like quarantines and curfews are needed. “What
we were doing 10 years ago and what we are doing now is vastly
different,†says Wiesen. “There is a tremendous opportunity here, and
hopefully by [the next pandemic], the use of technology and data
analytics is going to be light-years ahead of where it is today.â€
Posted by AGORACOM-JC
at 1:03 PM on Wednesday, March 18th, 2020
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
Why 5G enabled healthcare is important for patients and spatial computing
By empowering new tools, 5G enabled healthcare may help aid in caring for patients and preparing for complex medical procedures.
While augmented reality (AR), virtual reality (VR) and spatial computing are already being used in healthcare on a limited basis, 5G enabled healthcare may eventually further enhance a doctor’s ability to deliver innovative, less invasive treatments.
Among 5G’s many ultimate potential applications, some of the most exciting involve its role in simulating complex medical scenarios and enabling alternative treatments for the critically ill.
5G enabled healthcare
5G is the fifth generation of cellular wireless technology, which can
offer massive connection power and fast internet speed for data
transfer. Implementation of 5G technology accelerated the demand for
various healthcare technologies such as the Internet of Medical Things, AR/VR, artificial intelligence (AI), remote medical learning, and remote patient monitoring to name a few.
Patient real time information is important data for doctors to take
decisions in a critical situation. This has accelerated the demand for
advanced technologies in the healthcare sector. For instance,
telemedicine requires an advanced network that offers support in real
time, providing high-quality video communication without slowing down
the facility’s network. Integration of 5G network in existing
infrastructure provides real time data transfer of images, documents,
and real time videos for video-based medical consultations, to improve
the quality of care.
North America held a dominant share of the global 5G enabled
healthcare services market in 2019. It is expected to continue its
dominance throughout the forecast period. The US and Canada are the
major countries that drive the 5G enabled healthcare services market in
the region.
Demand for 5G
The aging population is expected to increase the demand for advanced
solutions such as mHealth solutions, and home healthcare, which require
high-speed internet. According to the Population Reference Bureau, in
2018, 15% of the total North American population was above the age of 65
and is expected to reach 23% by 2050. Hence, the increasing aging
population is accelerating the demand for 5G enabled healthcare
services.
The 5G enabled healthcare services market in Asia Pacific is expected
to expand at a fast-paced CAGR during the forecast period. India,
China, Japan, and Australia are major countries of the 5G enabled
healthcare services market in the region.
Increasing adoption of advanced communication solutions in the
healthcare industry, majorly in developing countries where health care
systems are often unprepared to tackle the challenges of a growing
elderly population, has raised the need for high-speed internet services
in the healthcare sector. Hence, this augments the adoption rate of 5G
services in the healthcare industry.
Tags: EKG, mhealth, small cap stocks, stocks, tsx, tsx-v Posted in CardioComm Solutions | Comments Off on Why #5G enabled healthcare #Mhealth is important for patients and spatial computing SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca
Posted by AGORACOM-JC
at 6:12 PM on Thursday, March 12th, 2020
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
Coronavirus Scare Gives Telehealth an Opening to Redefine Healthcare
With the coronavirus threatening to become a pandemic, health
systems and telehealth vendors see this as an opportunity to bring
connected health to the forefront – and reshape the future of
healthcare.
Most see the exercise as an extension of their preparations for flu
season. Some see this as an opportunity to lobby for telehealth adoption
across the board, saying a possible epidemic offers ample evidence of
the value of telehealth and mHealth.
Defining Telehealth’s Value in a Changing Landscape
“COVID-19 is different because we do not know all the factors
surrounding transmission and its effects on patients,†Jason Hallock,
Chief Medical Officer for SOC Telemed, points out. “Because coronavirus
is new and there have been a significant number of deaths, the
uncertainty surrounding that is scaring both patients and the general
public. Our healthcare workers do not have all the answers
yet. Telehealth providers are challenged to make recommendations when
there are still many unknowns. Telemedicine can be useful to evaluate
and reassure patients in alternative settings, and also can be used to
help patients decide who needs to be seen in the hospital or an
alternative setting like an urgent care.â€
Hallock says telehealth can help by enabling healthcare providers to
treat isolated patients, thus preventing the spread of what has so far
been an extremely contagious virus.
In a Q&A with mHealthIntelligence, Peter Antall, MD,
President and Chief Medical Officer for American Well, offered an
in-depth take on how telehealth might be used.
Q. Telehealth has long been seen as an ideal means of
expediting care during flu outbreaks. How is the coronavirus scare
different? Does this pose any unique challenges that telehealth can
address?
A. The novel coronavirus, or COVID-19, is similar to
influenza in how it is transmitted (airborne), how symptoms manifest
themselves, and the fear it stirs among those individuals at risk. When
evaluating patients through telehealth, we use similar methodology as
that used for influenza, except that the current Centers for Disease
Control and Prevention (CDC) recommendations call for risk
stratification based on known exposure or travel to endemic areas and
referral for testing for those at high risk or those who are sick enough
to need hospital care. Also, unlike with influenza, there are no
current specific treatments, like antivirals, for the coronavirus at
this time.
If local person-to-person spread expands to wide community spread, we
expect care will need to evolve to a method that is quite similar to
how we treat influenza today. Under those circumstances, we will likely
begin diagnosing coronavirus-like illness (CLI) on a clinical basis,
without testing. We would likely then only be expected to refer
inpatients with CLI who need hospital care clinically, while those with
milder symptoms will likely be treated and monitored at home so as to
limit the spread of this disease and not overwhelm our healthcare
facilities.
In this way, telehealth is an ideal venue for an outbreak like this.
We can increase access to care. We can offer care that is commensurate
with the acuity and nature of the symptoms and make referrals as needed.
This helps with infection prevention and control and also allows
patients to receive their care in the home without exposing themselves
to further illness.
One other notable point is the potential for telehealth to help in
providing routine care for other conditions and offset coronavirus fears
in the . Patients have other healthcare needs unrelated to coronavirus,
but many are afraid to go to healthcare settings for fear of catching
disease. This has begun to result in a migration of patients to
telehealth. For example, on February 25, we saw telehealth urgent care
patient volume that was 11 percent higher than expected. Many patients
are now sharing anecdotes indicating they were afraid to sit in a
waiting room, so they used telehealth instead.
Q. Are there new tools or technologies available that can be useful in dealing with the coronavirus?
A. Telehealth itself is a tool in this fight. Keep
in mind that there are many varieties of telehealth. It can be used to
connect a doctor or other provider with a patient in the home via
smartphones or tablets. It can also be used for provider
(specialist)-to-provider consultations in remote areas, for example.
Telehealth carts also exist in healthcare settings and can be used not
only to import care, but also to limit healthcare workers’ exposure to
the virus by using a cart in the isolation room. We see patients
primarily through live video interactions, but we also can fall back to
informed telephone calls, synchronous chatting for therapy and
asynchronous secure messaging for ongoing communications.
The use of symptom trackers and chatbots is another promising area
for coronavirus response. These technologies allow algorithms to be
created and adjusted as more is learned about the coronavirus. These
bots interact with patients and can perform assessments, triage and
ongoing support. The bots can even escalate an interaction to a
telehealth encounter or refer the patient for in-person care.
Finally, home monitoring and medical tricorders are another promising
approach to care. Traditional remote patient monitoring has established
value for managing certain chronic conditions, but the next wave of
home monitoring includes consumer devices like smartwatches (like
the Apple Heart Study), home TVs, and home medical tricorders
like Tytocare that can perform a remote examination. These tools aid
clinicians and patients and provide more robust health data conveniently
from the home setting. Providers can also use the data generated to
better care for the patient or regularly monitor certain conditions.
Q. What must care providers know about telehealth before using it to deal with the coronavirus?
A. Providers must know and understand their role in
this or any other healthcare crisis. They should be well informed and
trained to follow current CDC or World Health Organization guidelines.
They should also understand that telehealth is a powerful tool for
helping fight this outbreak. And they should know that telehealth is a
safe way to treat and/or triage these patients. Whether the provider is a
primary telehealth provider or is not using telehealth today, there is a
real opportunity to participate and play a role in the response.
Providers who have a brick-and-mortar practice should be encouraged
to use telehealth as a triage tool. Providers also need to understand
that during this time, patients with other non-respiratory conditions
also need care. These patients should be afforded a safe way to access
care without risk of infection. Telehealth is also a tool to aid in this
process, as some patients are fearful of going to healthcare facilities
right now. The office-based provider can likewise process other
patients by practicing this way.
Q. What are the barriers or challenges associated with using telehealth to deal with the coronavirus scare?
A. Telehealth visits are typically sufficient to
complete a robust initial assessment. This allow the provider to assign a
risk category, make other diagnoses, or deem the patient as “worried
well.†Some patients may require additional care, as most telehealth in
the home lacks certain medical peripherals that might be needed. Other
reasons for referral would include a high-risk patient who needs to be
tested or a patient who requires escalation of care due to the severity
of their illness. Telehealth visits are generally sufficient for
screening patients, assigning a risk category, answering questions and
recommending the next steps a patient should take.
The barriers to telehealth—such as instances when the patient and
provider do not yet have a relationship—are easily overcome providers
receive similar training around the use of telehealth and as
longitudinal patient records become more available to guide care.
Occasionally the lack of medical peripherals or the inability to touch
the patient during an exam is a barrier, as some patients need hands on
care (e.g., IV, procedures). We have policies that mitigate these
problems in most cases. However, on occasion, a telehealth patient must
be referred for in-person evaluation.
Q. Is there anything that the CDC or any other government
agency can do to support telehealth adoption to deal with the
coronavirus?
A. It is useful for the CDC (and the WHO) to
highlight the important role of telehealth in this outbreak because it
certifies our role within the broader medical community and raises
awareness about this tool.
It would be helpful if the CDC were to make specific recommendations
to telehealth providers that relate to telehealth evaluation of the
coronavirus and associated referrals, coding and monitoring. It would
also be helpful if the CDC were to play a role in advocacy efforts
focused on government reimbursement, particularly in this emergency
situation. Efforts to increase consumer awareness about telehealth as a
safe option for care also could prove essential. When this outbreak
settles down, we would encourage the CDC and HHS to collaborate around
coronavirus standards of care and preparedness so that patients can
expect telehealth providers to be ideally prepared and well-coordinated
for the next outbreak and so that we can offer high-quality care in this
manner to all Americans.
We also believe that our public health system would benefit greatly
from owning its own telehealth network infrastructure. This would allow
the CDC to better scale up, solve for geography and improve
surveillance. It would even allow its public health workers to use
technology to monitor patients under quarantine in the home, saving
themselves travel and limiting healthcare workers’ exposure.
Q. What more can be done with telehealth in the future to
plan for these types of outbreaks, or to perhaps address them before
they become serious?
A. Much needs to be done throughout our country to
better prepare. We need permanent leaders placed at the U.S. Department
of Health and Human Services, the National Institutes for Health, the US
Department of Homeland Security and other key areas, and we need to
reinstate a pandemic-preparedness role at the National Security Council.
We need to fund international efforts to improve screening and research
for emerging diseases, and we need surveillance programs and good
international coordination. We need to fund (not decrease funding) for
our frontline groups, like the CDC, HHS and local public health
services. These are our fighters, and we need them ready and funded
properly as an outbreak like this is a national security issue. We need
stockpiles of materials. Finally, we should be partnering with the
pharmaceutical industry on affordable medications and vaccine research.
Our national telehealth operation today acts like an emergency alert
system. We see cases or potential cases before they are reported. At
American Well, our influenza activity indicator map is more accurate and
more timely than that of the CDC. We already play a meaningful role in
many disease states, including outbreaks. There are still many adoption
and awareness challenges that exist when it comes to telehealth.
Hopefully this unfortunate event will help consumers, providers and
others start to more clearly see how they can and should use telehealth
for future healthcare needs.
Another barrier that we continue to work on is that of reimbursement.
Telehealth is a cost-effective way of receiving care, but it is still
not always a covered benefit by insurance. Most commercial plans are
reimbursing and there is increasing adoption in Medicare Advantage and
Medicaid managed care. But there are still gaps, including a big gap in
fee-for-service coverage for Medicare coverage in the home. Efforts at
reform are underway (see the CONNECT Act), but more work needs to be done so that all Americans can take advantage of this amazing service.
Additionally, with coordination being so important during outbreaks
like this, the simple step of integrating telehealth with other health
information systems, such as EHRs or clinical-decision support, can make
care more seamless and foster better care coordination. This would
speed up access to critical care. Case in point: Consider a scenario
where a patient consults with a physician over a telehealth network and
displays symptoms of COVID-19 while presenting one or more correlating
risk factors. The physician could easily document the experience,
dispatch an alert to a local ED, and ensure precautions are taken by
medical staff to usher this patient into a contained room or unit to
begin testing and treatment. We’re working to ensure this type of
communication is happening at all levels, but there’s still much room
for improvement on this front.
Health System Execs Respond to the Threat
In an op-ed prepared for the Alliance for Connected Care, Todd J.
Vento, MD, MPH, Intermountain Healthcare’s Medical Director of
Infectious Diseases Telehealth Service; Ethan Booker, MD, Medical
Director of MedStar’s Telehealth Innovation Center; and Lawrence “Rustyâ€
Hofmann, MD, Stanford Health’s Medical Director of Digital Health, made
their pitch for telehealth:
“Telehealth, which has proven to be a very useful tool in
addressing patient needs during flu season, will improve our collective
ability to address COVID-19 if it hits on a larger scale. Telehealth offers several advantages over in-person care in the event of a pandemic.
One key advantage of telehealth is speed,†the three wrote.
“Patients can access clinicians 24/7 without an appointment or physical
trip to the doctor. Using telehealth, our providers in the Stanford
Primary Care team, MedStar Health and Intermountain Healthcare have been
actively evaluating and treating patients with influenza. Current
providers at Stanford Health estimate that almost 50% of patients are
getting oseltamivir (Tamiflu). Because there is no current,
specific medication for Coronavirus, we must be able to advise patients
of reasonable self-directed treatment and surveillance to keep them
home.
Keeping patients at home is a significant advantage of
telehealth. In-home video visits limit community exposure by allowing
patients to avoid contact with other patients in waiting rooms and
direct contact with providers during the exam. Our health systems have
providers who are equipped to work from their own homes, significantly
increasing the safety of providers and bolstering the workforce to
respond to crisis. Workforce readiness in a crisis that may include
such dramatic measures as school and day care closures is a significant
concern for health systems which may be strained to respond. Health
systems are also using telehealth to continue surveillance of patients
already identified as at risk while keeping them at home.
Next, telehealth ensures that treatment in brick-and-mortar
settings is reserved for high-need patients. Moreover, with patients
being seen in their own homes, providers and health systems will be able
to triage and screen exponentially more patients with telehealth vs. an
in-person visit.
Finally, telehealth allows patients who do not have access to
infectious diseases (ID) specialists to access this specialized care
from the small number of experts across the country. When Intermountain
first offered ID telehealth consultation to rural systems throughout the
west, one provider fielded 1,000 consultation requests in the first
fifteen months. To date, the service has provided telehealth care to
over 4,700 patients, 50 percent of whom are over 65 years old.
Each of these advantages illustrate how telehealth can thwart the
spread of COVID-19 and stop it from overwhelming our already stretched
medical system.â€
The three health executive also urged lawmakers to take action to reduce barriers to telehealth that have kept adoption low:
“Congress must act to ensure that seniors – a particularly
vulnerable population generally and for this virus in particular – are
able to receive necessary triage and care through telehealth.
Today, there are restrictions in Medicare that prevent providers
outside of very rural areas from being paid for care provided through
telehealth. As a result, many providers do not offer telehealth services
to seniors. The lack of reimbursement creates a perverse incentive of
encouraging patients to come for in-person care, which will only
overwhelm our health system as well as augment the virus’s spread.
Congress must give the Secretary of Health and Human Services the
ability to waive these restrictions in times of public health
emergencies. As part of the bipartisan, bicameral CONNECT for Health
Act, telehealth champions in Congress foresaw this need and drafted a
provision that would give the Secretary the ability to waive telehealth
restrictions just as he/she would waive Conditions of Participation,
Stark Laws licensure, or other requirements when public health
emergencies are declared.â€
Posted by AGORACOM-JC
at 1:15 PM on Monday, March 9th, 2020
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
Healthcare IT Market Worth $511.06 Billion by 2027
Healthcare IT market is expected to grow at a CAGR of 13.8% from 2019 to reach $511.06 billion by 2027.
London, March 06, 2020 – According to a new market research report “Healthcare IT Market
by Product (EMR, mHealth, PHM, RIS, PACS, RCM, Healthcare Analytics,
Telehealth, SCM, HIE), Component (Software, Service), Delivery Mode
(Web, Cloud) and End User (Hospital, Payer, Pharmacy, Ambulatory,
Homecare)- Global Forecast to 2027â€, published by Meticulous
Research®, the healthcare IT market is expected to grow at a CAGR of
13.8% from 2019 to reach $511.06 billion by 2027.
Health Information Technology (Healthcare IT) is a broad term that
defines the technology and infrastructure utilized to record, analyze,
and share patient health data in healthcare organizations. The aim of
Healthcare IT solutions is to offer better care for patients and help
accomplish health equity. It also endorses recording of patient data to
improve healthcare delivery and allow for analysis of information for
both healthcare practitioners and ministry of health/government
agencies.
With increasing pressure to curtail healthcare cost and improve
healthcare quality, investments in healthcare IT are gaining traction
and are largely driven by the need for savings, economies of scale, and
improving cash flow. According to a survey performed by Octopus group,
more than 100 global institutional investors have planned to increase
their investment in healthcare infrastructure, including health IT, by
$200 billion over the next five years. By adopting various healthcare IT
solutions such as EHR, PACS, and CPOE among others, healthcare
organizations have reduced the operational cost and improved savings
along with better patient care. For instance, with increasing adoption
of Cerner Dynamic Documentation platform, Northern Light Health (U.S.)
saved an estimated $1.3 million annually, by increasing provider
efficiency, improving satisfaction with their electronic health record,
and streamlining the discharge process. Similarly, by adopting Cerner
ITWorks, University of Missouri Health Care (U.S.) reduced the
organization’s IV obsolescence rate by more than 43% over three months.
In addition, the university also adopted Cerner’s revenue cycle
management solutions in 2018.
The healthcare IT solutions market study presents historical market
data in terms of value (2017, and 2018), estimated current data (2019),
and forecasts for 2027 – by product, component, delivery mode, end-user,
and geography. The study also evaluates industry competitors and
analyzes their market share at the global and regional level.
Based on product type, the healthcare providers solutions segment
accounted for the largest share of the healthcare IT market and is
slated to grow faster during the forecast period. The large share of
this segment is primarily attributed to the factors such as growing
focus on patient safety & care, increasing demand for integrated
healthcare solutions, rising investments in development of healthcare
infrastructure in emerging countries, increasing number of government
initiatives & regulatory mandates on implementing eHealth solutions,
increasing demand for quality healthcare, and rising awareness about
electronic health records (EHRs). In addition, growing geriatric
population & related ailments and patient workload on healthcare
systems across the globe are also driving adoption of digitization
solutions among healthcare providers.
Based on component type, the services segment held the largest share
of the overall healthcare IT market. The largest share of this segment
is mainly attributed to the increasing need to reduce healthcare costs,
shift towards cloud-based services, rising adoption of digital solutions
across healthcare organizations, and growing need to reduce
administrative overheads of the healthcare industry.
Based on delivery mode, the overall healthcare IT market is segmented
into web/cloud based and on-premises. Web & cloud-based solutions
accounted for the largest share of the overall healthcare IT solutions
market owing to its benefits such as on lower upfront cost, on-demand
self-serving deployment model, excessive storage flexibility, and
greater security.
Based on the end user, healthcare providers held the largest share of
the overall healthcare IT market and is projected to grow at a fastest
CAGR during the forecast period. The largest share of this segment is
mainly attributed to rising patient volume, growing awareness about
electronic health records (EHRs), growing healthcare spending by the
countries across globe, and increasing adoption of healthcare IT
solutions by healthcare providers.
The report also includes extensive assessment of the product
portfolio, geographic analysis, and key strategic developments adopted
by leading market participants in the industry over the past 4 years
(2016–2019). The healthcare IT solutions market has witnessed number of
new product launches, agreements, partnerships & collaborations,
expansions, and acquisitions in the recent years. For instance, in
October 2019, Cerner collaborated with ResMed (U.S.) to help providers
make more informed treatment decisions, control costs, and deliver
seamless care across health systems. Similarly, in July 2019, McKesson
opened its new distribution center in Puyallup, Washington, U.S. to
serve hospitals, health systems, community pharmacies, and national
retail pharmacies across the state of Washington.
The key players operating in the global healthcare IT market are
McKesson Corporation (U.S.), Optum Health (U.S.), International Business
Machine Corporation (IBM) (U.S.), Allscripts Healthcare Solutions, Inc.
(U.S.), athenahealth, Inc. (U.S.), Epic Systems Corporation (U.S.),
Dell Technologies Inc. (U.S.), GE Healthcare (U.S.), Cerner Corporation
(U.S.), Oracle Corporation (U.S.), Cognizant Technology Solutions
Corporation (U.S.), Nuance Communications, Inc. (U.S.), eClinicalWorks
(U.S.) NextGen Healthcare, Inc. (U.S.), Computer Programs and Systems,
Inc. (CPSI) (U.S.), Conifer Health Solutions, LLC. (U.S.), 3M Company
(U.S.), Koninklijke Philips N.V. (The Netherlands), and Infor, Inc.
(U.S.) among others.
Tags: EKG, mhealth, small cap stocks, stocks Posted in CardioComm Solutions | Comments Off on Healthcare IT #Mhealth Market Worth $511.06 Billion by 2027 SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca
Posted by AGORACOM-JC
at 12:14 PM on Thursday, March 5th, 2020
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
DEA Proposes New Mhealth Rule for Substance Abuse Treatment
A proposed rule change would allow providers to use mHealth tools
more freely in substance abuse treatment programs, but it isn’t the rule
that telehealth advocates have been anticipating.
March 04, 2020 – Federal officials have proposed easing restrictions
on the use of mHealth in substance abuse programs – but the changes
aren’t what everyone has been expecting.
“The NTP registrants that operate or wish to operate mobile
components (in the state that the registrant is registered in) to
dispense narcotic drugs in schedules II-V at a remote location for the
purpose of maintenance or detoxification treatment would not be required
to obtain a separate registration for a mobile component,†a summary of
the rule states.
“This proposed rule would waive the requirement of a separate
registration at each principal place of business or professional
practice where controlled substances are dispensed for those NTPs with
mobile components that fully comply with the requirements of the
proposed rule, once finalized,†the summary continues. “These revisions
to the regulations are intended to make maintenance or detoxification
treatments more widely available, while ensuring that safeguards are in
place to reduce the likelihood of diversion.â€
The notice is different from what telehealth and mHealth providers
have been waiting for: a rule that would ease federal restrictions on
the prescription of scheduled drugs via telemedicine, and one that
federal officials had been expected to unveil. It even prompted Virginia
Sen. Mark Warner to issue a press release congratulating the DEA on
making that move.
“The opioid and addiction epidemic has had a devastating impact on communities in Virginia and across the country,†Warner, who had sent a letter to the DEA in January,
said in a press release that has since been deleted. “We need to use
every tool at our disposal to ensure that individuals struggling with
addiction can access the treatment they need, and telehealth is an
important part of that. I am pleased the DEA has finally issued proposed
rulemaking that will improve telehealth access for these patients and I
hope they will work quickly to finalize this rulemaking once
stakeholders have had an opportunity to weigh in.â€
That deadline passed without action. In November, the Justice Department announced plans to issue a proposed rule to
create that registration process. But nothing has happened since then,
and the DEA and other federal agencies have refused to give any updates.
Last month’s ruling leaves healthcare providers looking for more
leeway in treating substance abuse issues both pleased and disappointed.
It’s a step in the right direction for programs using digital health
tools, but not the leap forward that so many have been anticipating.
Physician Groups Order The Heartcheck(TM) Cardibeat For In-Home Arrhythmia And Atrial Fibrillation Monitoring
Confirms market traction with orders being placed by physician
groups for the newly launched HeartCheck™ CardiBeat Handheld ECG monitor
and GEMS™ Mobile Smartphone app for prescribed in-home arrhythmia
monitoring.
Partners in Advanced Cardiac Evaluation, the largest arrhythmia
practice in Ontario (Canada) placed a first order of the HeartCheck™
CardiBeat Handheld ECG monitors and is recommending its patients to use
the devices for one year of in-home, self-monitoring with an emphasis on
detecting a recurrence of Atrial Fibrillation following cardiac
ablation treatment for AF.